115 related articles for article (PubMed ID: 20594950)
1. Interleukin-17 is involved in alpha-naphthylisothiocyanate-induced liver injury in mice.
Kobayashi M; Higuchi S; Mizuno K; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
Toxicology; 2010 Sep; 275(1-3):50-7. PubMed ID: 20594950
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of Danning tablet on acute livery injury with cholestasis induced by α-naphthylisothiocyanate in rats.
Ding LL; Zhang BF; Dou W; Yang L; Zhan CS; Wang ZT
J Ethnopharmacol; 2012 Mar; 140(2):222-9. PubMed ID: 22274634
[TBL] [Abstract][Full Text] [Related]
3. Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury.
Xu J; Lee G; Wang H; Vierling JM; Maher JJ
Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G734-41. PubMed ID: 15130876
[TBL] [Abstract][Full Text] [Related]
4. Th2 cytokine-mediated methimazole-induced acute liver injury in mice.
Kobayashi M; Higuchi S; Ide M; Nishikawa S; Fukami T; Nakajima M; Yokoi T
J Appl Toxicol; 2012 Oct; 32(10):823-33. PubMed ID: 22407903
[TBL] [Abstract][Full Text] [Related]
5. Halothane-induced liver injury is mediated by interleukin-17 in mice.
Kobayashi E; Kobayashi M; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
Toxicol Sci; 2009 Oct; 111(2):302-10. PubMed ID: 19633216
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol effectively attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms.
Wang T; Zhou ZX; Sun LX; Li X; Xu ZM; Chen M; Zhao GL; Jiang ZZ; Zhang LY
Acta Pharmacol Sin; 2014 Dec; 35(12):1527-36. PubMed ID: 25418378
[TBL] [Abstract][Full Text] [Related]
7. Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats.
Yan JY; Ai G; Zhang XJ; Xu HJ; Huang ZM
J Ethnopharmacol; 2015 Aug; 172():202-13. PubMed ID: 26133062
[TBL] [Abstract][Full Text] [Related]
8. The role of invariant natural killer T cells in experimental xenobiotic-induced cholestatic hepatotoxicity.
Nong C; Zou M; Xue R; Bai L; Liu L; Jiang Z; Sun L; Huang X; Zhang L; Wang X
Biomed Pharmacother; 2020 Feb; 122():109579. PubMed ID: 31794947
[TBL] [Abstract][Full Text] [Related]
9. Involvement of immune-related factors in diclofenac-induced acute liver injury in mice.
Yano A; Higuchi S; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
Toxicology; 2012 Mar; 293(1-3):107-114. PubMed ID: 22285467
[TBL] [Abstract][Full Text] [Related]
10. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
Tang X; Yang Q; Yang F; Gong J; Han H; Yang L; Wang Z
J Ethnopharmacol; 2016 Dec; 194():63-71. PubMed ID: 27582267
[TBL] [Abstract][Full Text] [Related]
11. Effects of Kupffer cell depletion on acute alpha-naphthylisothiocyanate-induced liver toxicity in male mice.
Cullen JM; Faiola B; Melich DH; Peterson RA; Jordan HL; Kimbrough CL; Prescott JS; Miller RT
Toxicol Pathol; 2013 Jan; 41(1):7-17. PubMed ID: 22886348
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis.
Joshi N; Ray JL; Kopec AK; Luyendyk JP
J Biochem Mol Toxicol; 2017 Jan; 31(1):1-7. PubMed ID: 27605088
[TBL] [Abstract][Full Text] [Related]
13. Role of the lipid-regulated NF-κB/IL-6/STAT3 axis in alpha-naphthyl isothiocyanate-induced liver injury.
Fang ZZ; Tanaka N; Lu D; Jiang CT; Zhang WH; Zhang C; Du Z; Fu ZW; Gao P; Cao YF; Sun HZ; Zhu ZT; Cai Y; Krausz KW; Yao Z; Gonzalez FJ
Arch Toxicol; 2017 May; 91(5):2235-2244. PubMed ID: 27853831
[TBL] [Abstract][Full Text] [Related]
14. IL-4 mediates dicloxacillin-induced liver injury in mice.
Higuchi S; Kobayashi M; Yoshikawa Y; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
Toxicol Lett; 2011 Feb; 200(3):139-45. PubMed ID: 21094227
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor contributes to neutrophil CD11b expression in alpha-naphthylisothiocyanate-treated mice.
Luyendyk JP; Flanagan KC; Williams CD; Jaeschke H; Slusser JG; Mackman N; Cantor GH
Toxicol Appl Pharmacol; 2011 Feb; 250(3):256-62. PubMed ID: 21070799
[TBL] [Abstract][Full Text] [Related]
16. Endotoxin tolerance and polymyxin B modify liver damage and cholestasis induced by a single dose of alpha-naphthylisothiocyanate in the rat.
Calcamuggi G; Lanzio M; Dughera L; Babini G; Emanuelli G
Arch Toxicol; 1992; 66(2):126-30. PubMed ID: 1605727
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease.
Thatch KA; Schwartz MZ; Yoo EY; Mendelson KG; Duke DS
J Pediatr Surg; 2008 Dec; 43(12):2169-73. PubMed ID: 19040928
[TBL] [Abstract][Full Text] [Related]
18. Involvement of immune- and inflammatory-related factors in flucloxacillin-induced liver injury in mice.
Takai S; Higuchi S; Yano A; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
J Appl Toxicol; 2015 Feb; 35(2):142-51. PubMed ID: 24652713
[TBL] [Abstract][Full Text] [Related]
19. Platelets and alpha-naphthylisothiocyanate-induced liver injury.
Bailie MB; Pearson JM; Lappin PB; Killam AL; Roth RA
Toxicol Appl Pharmacol; 1994 Dec; 129(2):207-13. PubMed ID: 7992311
[TBL] [Abstract][Full Text] [Related]
20. Cholestatic models induced by lithocholic acid and α‑naphthylisothiocyanate: Different etiological mechanisms for liver injury but shared JNK/STAT3 signaling.
Xu G; Dai M; Zheng X; Lin H; Liu A; Yang J
Mol Med Rep; 2020 Aug; 22(2):1583-1593. PubMed ID: 32626965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
